Henry Schein, Inc. (NASDAQ:HSIC) Stock Position Lowered by Renaissance Technologies LLC

Renaissance Technologies LLC trimmed its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 47.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 213,612 shares of the company's stock after selling 189,900 shares during the period. Renaissance Technologies LLC owned approximately 0.17% of Henry Schein worth $14,782,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Invesco Ltd. increased its stake in Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock worth $343,468,000 after acquiring an additional 17,552 shares during the last quarter. FMR LLC grew its holdings in shares of Henry Schein by 6.6% during the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock worth $242,064,000 after purchasing an additional 217,143 shares during the period. Geode Capital Management LLC grew its stake in shares of Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after buying an additional 14,876 shares in the last quarter. Lyrical Asset Management LP purchased a new position in Henry Schein in the 4th quarter worth approximately $126,655,000. Finally, Clarkston Capital Partners LLC raised its stake in shares of Henry Schein by 24.8% during the fourth quarter. Clarkston Capital Partners LLC now owns 1,744,225 shares of the company's stock valued at $120,700,000 after purchasing an additional 346,420 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on HSIC. UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Barrington Research restated an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Finally, StockNews.com downgraded Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $81.10.

Henry Schein Price Performance

HSIC traded up $1.44 on Friday, reaching $64.73. The company had a trading volume of 1,390,004 shares, compared to its average volume of 1,616,977. The company has a market capitalization of $7.93 billion, a P/E ratio of 26.64, a PEG ratio of 2.13 and a beta of 0.84. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a fifty day moving average of $70.41 and a 200-day moving average of $71.98. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the business earned $0.66 earnings per share. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.